U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07368127) titled 'A Study of TPD3310 in Patients With Advanced Malignant Tumors' on Jan. 03.
Brief Summary: This study is a multicenter, open phase I clinical study of dose escalation,cohort expansion study to evaluate the safety,tolerability,pharmacokinetics,pharmacodynamics, and preliminary efficacy of TPD3310 in patients withadvanced malignant solid tumors.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Advanced Malignant Solid Tumors
Intervention:
DRUG: TPD3310 injection
* Phase Ia: Single and Multiple Dose Escalation. (1) Dosage form: injection. (2) Dosage: 6 dose groups, 50 mg, 100 mg, 200 mg, 350 mg, 500 mg, 650 mg,.-A...